Kristen Alexander serves as Executive at LEXICON PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Kristen Alexander has executed 12 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 28, 2024 involved exercising options for 15,927 shares valued at $0.
Kristen Alexander currently holds 59,593 shares of LEXICON PHARMACEUTICALS, INC. (LXRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kristen Alexander has been a net neutral trader of LXRX stock. They have purchased $0 and sold $0 worth of shares.
Kristen Alexander's most recent insider trade was on Feb 28, 2024, when they sold 15,927 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 2,700 |
| $N/A |
| Discretionary |
| Feb 28, 2024 | LXRX | $0 | Option Exercise | 10,616 | $N/A | Discretionary |
| Feb 28, 2024 | LXRX | $30.9K | Payment | 11,793 | $2.62 | Discretionary |
| Feb 28, 2023 | LXRX | $0 | Option Exercise | 10,617 | $N/A | Discretionary |
| Feb 28, 2023 | LXRX | $11.6K | Payment | 5,330 | $2.17 | Discretionary |
| Feb 28, 2023 | LXRX | $0 | Option Exercise | 2,700 | $N/A | Discretionary |
| Feb 28, 2023 | LXRX | $0 | Option Exercise | 5,400 | $N/A | Discretionary |
| Feb 28, 2022 | LXRX | $9.5K | Payment | 3,337 | $2.85 | Discretionary |
| Feb 28, 2022 | LXRX | $0 | Option Exercise | 2,700 | $N/A | Discretionary |
| Feb 28, 2022 | LXRX | $0 | Option Exercise | 5,400 | $N/A | Discretionary |
| Feb 28, 2022 | LXRX | $0 | Option Exercise | 3,200 | $N/A | Discretionary |